Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Onconova Therapeutics, Inc. (ONTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/19/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
12/19/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/17/2021 3 Gelder Mark S. MD (Chief Medical Officer) has filed a Form 3 on Onconova Therapeutics, Inc.
06/08/2020 3 Shoemaker Mary Teresa (Director) has filed a Form 3 on Onconova Therapeutics, Inc.
09/25/2019 3 ARMISTICE CAPITAL, LLC (10% Owner) has filed a Form 3 on Onconova Therapeutics, Inc.
12/14/2018 3 OLER ABRAHAM N. (VP Corp Dev & Gen Counsel) has filed a Form 3 on Onconova Therapeutics, Inc.
11/07/2018 3 Woodman Richard Charles (Chief Medical Officer) has filed a Form 3 on Onconova Therapeutics, Inc.
02/12/2018 3 683 Capital Management, LLC (10% Owner) has filed a Form 3 on Onconova Therapeutics, Inc.
08/17/2016 3 Form 3 - Initial statement of beneficial ownership of securities
05/20/2016 3 Form 3 - Initial statement of beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy